New vaccine aims to clear HPV and reverse cervical precancer
Disease control
Not yet recruiting
This study is testing an experimental vaccine called PVX4 to see if it can help the body clear HPV16 infection and reverse high-grade precancerous cervical lesions (CIN2/3). It will enroll about 138 women aged 18-60 who have confirmed HPV16+ CIN2/3 and compare the vaccine to a pl…
Phase: PHASE2 • Sponsor: PapiVax Biotech, Inc. • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC